Considerations for patients with psoriasis travelling under immunosuppression
Standard
Considerations for patients with psoriasis travelling under immunosuppression. / Stephan, Brigitte; Tittelbach, Jörg; Bühler, Silja.
In: J DTSCH DERMATOL GES, Vol. 19, No. 2, 02.2021, p. 197-207.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Considerations for patients with psoriasis travelling under immunosuppression
AU - Stephan, Brigitte
AU - Tittelbach, Jörg
AU - Bühler, Silja
N1 - © 2020 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.
PY - 2021/2
Y1 - 2021/2
N2 - With the establishment of modern systemic therapies for psoriasis, comprehensive consultation is required for travelling with immune modulation. Logistic aspects regarding transport and storage, climatic peculiarities of the country of travel and drug dependent risks regarding infections must be considered. Vaccinations and preventive measures are emphasized. Depending on the current national recommendations, special features of vaccinations while under immunosuppression must be taken into account.
AB - With the establishment of modern systemic therapies for psoriasis, comprehensive consultation is required for travelling with immune modulation. Logistic aspects regarding transport and storage, climatic peculiarities of the country of travel and drug dependent risks regarding infections must be considered. Vaccinations and preventive measures are emphasized. Depending on the current national recommendations, special features of vaccinations while under immunosuppression must be taken into account.
KW - Humans
KW - Immunosuppression Therapy
KW - Psoriasis
KW - Travel
KW - Vaccination
U2 - 10.1111/ddg.14377
DO - 10.1111/ddg.14377
M3 - SCORING: Review article
C2 - 33491922
VL - 19
SP - 197
EP - 207
JO - J DTSCH DERMATOL GES
JF - J DTSCH DERMATOL GES
SN - 1610-0379
IS - 2
ER -